Solís, K.H.; Romero-Ávila, M.T.; Rincón-Heredia, R.; Martínez-Morales, J.C.; García-Sáinz, J.A.
LPA3: Pharmacodynamic Differences Between Lysophosphatidic Acid and Oleoyl-Methoxy Glycerophosphothionate: Biased Agonism, Two Sites. Receptors 2024, 3, 555-573.
https://doi.org/10.3390/receptors3040029
AMA Style
Solís KH, Romero-Ávila MT, Rincón-Heredia R, Martínez-Morales JC, García-Sáinz JA.
LPA3: Pharmacodynamic Differences Between Lysophosphatidic Acid and Oleoyl-Methoxy Glycerophosphothionate: Biased Agonism, Two Sites. Receptors. 2024; 3(4):555-573.
https://doi.org/10.3390/receptors3040029
Chicago/Turabian Style
Solís, K. Helivier, M. Teresa Romero-Ávila, Ruth Rincón-Heredia, Juan Carlos Martínez-Morales, and J. Adolfo García-Sáinz.
2024. "LPA3: Pharmacodynamic Differences Between Lysophosphatidic Acid and Oleoyl-Methoxy Glycerophosphothionate: Biased Agonism, Two Sites" Receptors 3, no. 4: 555-573.
https://doi.org/10.3390/receptors3040029
APA Style
Solís, K. H., Romero-Ávila, M. T., Rincón-Heredia, R., Martínez-Morales, J. C., & García-Sáinz, J. A.
(2024). LPA3: Pharmacodynamic Differences Between Lysophosphatidic Acid and Oleoyl-Methoxy Glycerophosphothionate: Biased Agonism, Two Sites. Receptors, 3(4), 555-573.
https://doi.org/10.3390/receptors3040029